Nature Biotechnology · 1 Sept 2026 · Journal Article

Lessons from drug revenue life cycles: distributions across modalities and therapeutic areas.

Vogel, Cowan + 1 more

Abstract ↗AI briefThe abstract is read at the publisher; the brief is JClub's.

The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.

Read the brief in JClub →

Applying the FDA's plausible mechanism guidance across the rare disease landscape.
Nature Genetics · 9 Sept 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42717240
Open in JClub
Assessing Front-of-Package Labels: The U.S. Food and Drug Administration's Proposed Rule in Context.
Annals of Internal Medicine · 1 Sept 2026 · Editorial
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42441968
Open in JClub
Which outcomes of pharmacist-involved services are measured well enough to support decisions? A systematic review, meta-analysis, and evidence map of 266 randomised trials in China
medRxiv · 31 Aug 2026 · Preprint
Read the brief in JClub
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.1101/2024.07.25.24310734
Open in JClub

Journals this month

All journals →

Moving areas, week to 3 Oct 2026

All research areas →

Read